Looking for a Blood Epigenetic Signature to Predict Female Infertility
Università Vita-Salute San Raffaele
1,456 participants
Oct 16, 2023
OBSERVATIONAL
Conditions
Summary
The present research project aims to study the DNAm mechanisms underlying the reduction of fertility due to the progressive depletion of oocyte quality. Specifically, our project aims to build an epigenetic clock for MGCs by using outcomes that are certainly related to female fertility. The validation of such findings will be carried out on peripheral blood in order to guarantee its non-invasiveness and allow for any clinical transferability. In order to identify a blood epigenetic signature able to predict female infertility, we planned to explore the problem from different points of view by conducting several studies in different settings.
Eligibility
Inclusion Criteria1
- < age <43, Infertile woman undergoing ART, recurrent pregnancy loss
Exclusion Criteria1
- age < 18 or > 44, previous ovarian surgery, severe male factor infertility
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
examine the epigenetic profile of DNA extracted from MGCs and blood sample
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06098495